Immune Effector Cells

The main objective of FACT’s Immune Effector Cell Standards is to promote quality practice in immune effector cell administration. FACT also administers an associated voluntary, peer-led accreditation program that promotes patient safety, protects the research environment, and assists health care entities with achieving controlled processes, receiving grant funding, and gaining institutional support. FACT is committed to supporting efforts to make quality immune effector cellular therapy accessible to patients much like it did for blood and marrow transplantation and cord blood banking. Several resources are available to assist with understanding immune effector cells and implementing FACT Standards.
Ask FACT

FAQ

Ask a Peer

As a Matter of FACT

FACT was formally known as “FAHCT” (The Foundation for the Accreditation of Hematopoietic Cellular Therapy) until it expanded operations into other cellular therapies beyond hematopoietic cells.

Accreditation Success Story

Hospital Israelita Albert Einstein (HIAE) in Brazil is the first Bone Marrow Transplantation Center in Latin America to receive FACT accreditation. HIAE is accredited for autologous and allogenic transplantation. Read more